Injective Protocol's native token INJ traded at $7.19 on October 15, 2026, posting a sharp single-day decline of 9.56% that erased a portion of its recent monthly advance.
The 24-hour drop extended a modest weekly pullback of 2.94%, suggesting some near-term selling pressure has weighed on the token over the past several days. Despite the short-term weakness, INJ still holds a 30-day gain of 19.22%, indicating the token moved significantly higher over the broader monthly window before the recent retreat.
At its current price, Injective Protocol carries a market capitalization of $0.73 billion, reflecting the combined effect of the day's price decline on the token's overall valuation.
The session's move places INJ in negative territory on both a daily and weekly basis while leaving its longer 30-day performance solidly in the green, illustrating the contrast between recent short-term weakness and the token's stronger performance over the past month.
